Last reviewed · How we verify

NCT06601036

Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients

Recruiting now NA Last updated 19 September 2024
What this trial tests

NA trial testing Sevoflurane in Sevoflurane in 70 participants. Currently enrolling.

Timeline
17 September 2024
Primary endpoint
1 February 2025
1 February 2025

Quick facts

Lead sponsorTanta University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment70
Start date17 September 2024
Primary completion1 February 2025
Estimated completion1 February 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 18 to 50, any sex, with Sevoflurane or Sedation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare patient satisfaction and intubating conditions with fiber optic intubation under sevoflurane sedation versus airway blocks in difficult airway patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sevoflurane

Trials testing the same drug.

Other recruiting trials for Sevoflurane

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06601036.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing